Venous sinus stenting in idiopathic intracranial hypertension

Czech version

Authors: P. Skalický ¹; J. Malík ²; A. Mládek ³; F. Charvát ²; V. Beneš ¹; O. Bradáč ¹
Authors‘ workplace: Neurochirurgická a neuroonkologická, klinika 1. LF UK a ÚVN Praha ¹; Radiodiagnostické oddělení ÚVN Praha ²; Kognitivní systémy a neurovědy, Český, institut informatiky, robotiky a kybernetiky, ČVUT v Praze ³
Published in: Cesk Slov Neurol N 2020; 83/116(5): 566-569
Category: Letter to Editor
doi: https://doi.org/10.14735/amcsnn2020566

Sources

1. Markey KA, Mollan SP, Jensen RH et al. Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions. Lancet Neurol 2016; 15 (1): 78–91. doi: 10.1016/S1474-4422 (15) 00298-7.

2. Wall M. Idiopathic intracranial hypertension. Neurol Clin 2010; 28 (3): 593–617. doi: 10.1016/j.ncl.2010.03.003.

3. Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 2013; 81 (13): 1159–1165. doi: 10.1212/WNL.0b013e3182a55f17.

4. Wall M. Update on idiopathic intracranial hypertension. Neurol Clin 2017; 35 (1): 45–57. doi: 10.1016/j.ncl.2016.08.004.

5. Fargen KM, Liu K, Garner RM et al. Recommendations for the selection and treatment of patients with idiopathic intracranial hypertension for venous sinus stenting. J Neurointerv Surg 2018; 10 (12): 1203–1208. doi: 10.1136/neurintsurg-2018-014042.

6. Kalyvas A, Neromyliotis E, Koutsarnakis C et al. A systematic review of surgical treatments of idiopathic intracranial hypertension (IIH). Neurosurg Rev 2020 [ahead of print]. doi: 10.1007/s10143-020-01288-1.

7. Kwee RM, Kwee TC. Systematic review and meta--analysis of MRI signs for diagnosis of idiopathic intracranial hypertension. Eur J Radiol 2019; 116 : 106–115. doi: 10.1016/j.ejrad.2019.04.023.

8. Higgins JN, Owler BK, Cousins C et al. Venous sinus stenting for refractory benign intracranial hypertension. Lancet 2002; 359 (9302): 228–230. doi: 10.1016/S0140-6736 (02) 07440-8.